Clinical trial
Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPA
NCT00477503 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00477503 |
|---|---|
| Title | Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPA |
| Official title | Phase 1 Study Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPA |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Central Nervous System Tumors, Brain Tumors |
| Intervention type | Drug |
| Interventions | Gallium-67 Citrate (Ga-67), In-111 DTPA (In-111 pentetate) |
| Enrollment | 1 |
| Start date | May 1, 2007 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | May 23, 2007 |
| Last update posted | Aug 1, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: